During the past decade, Ocala Cardiovascular Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ocala Cardiovascular Research" #1 sponsor was "Zoll Medical Corporation" with 4 trials, followed by "Amgen" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Kowa Research Institute, Inc." with 2 trials sponsored and "NewAmsterdam Pharma" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ocala Cardiovascular Research" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ocala Cardiovascular Research" are "Severe Hypertriglyceridemia" (3 trials), "Cardiac Arrhythmia" (2 trials), "Dyslipidemias" (2 trials), "Heart Failure" (2 trials) and "Heart Failure With Preserved Ejection Fraction" (2 trials). Many other conditions were trialed in "Ocala Cardiovascular Research" in a lesser frequency.

Most popular intervention types in "Ocala Cardiovascular Research" are "Drug" (7 trials), "Device" (4 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arrhythmia Management System (AMS)" (2 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Obicetrapib" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ocala Cardiovascular Research" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Ocala Cardiovascular Research". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Ocala Cardiovascular Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ocala Cardiovascular Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".